Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

WHO’s director-general says COVID-19 vaccine may be available by year-end

Remarks were made at a WHO executive board meeting earlier this week

- PMLiVE

GSK and Vir Biotech expand phase 3 COVID-19 antibody study

Study extends into additional sites after positive safety assessment

- PMLiVE

Not your average training programme: why does allegro work so well?

By Nicky Griffin

- PMLiVE

AbbVie’s HIV therapy Kaletra fails to show efficacy in COVID-19

Drug failed to improved condition of hospitalised COVID-19 patients

- PMLiVE

Pfizer and BioNTech’s COVID-19 vaccine begins EMA evaluation

Vaccine is the second to undergo EMA's 'rolling review' process after AstraZeneca/Oxford Uni's candidate

- PMLiVE

Merck’s R&D chief Roger Perlmutter heads for the exit as Dean Li takes the helm

Perlmutter is set to join the board of AI drug discovery biotech Insitro

- PMLiVE

Multilingual remote conferencing and interpreting platforms in the era of COVID-19

Turning the pharmaceutical language behind vaccine development into engaging, accessible content

- PMLiVE

A day in the life of Becca McConnell a Senior Account Executive

We asked Becca McConnell to give us an insight into her role as Senior Account Executive at OPEN Health.

OPEN Health

- PMLiVE

The flexible salesforce

By John Procter

- PMLiVE

The importance of pharma intelligence in setting brand strategy

Looking at the different approaches that can be leveraged to assess the competition

- PMLiVE

Nearly 16,000 coronavirus cases left out of UK’s daily figures between 25 September and 2 October

PHE chief exec says ‘technical issue’ caused unreported coronavirus cases

- PMLiVE

Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November

Company will seek emergency use authorisation for experimental vaccine

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links